<document>
 <table id="Table 3">
  <caption text="

         Experimental and theoretical progress on LC-NE system and proposed link to SCZ symptoms.
        
">
  </caption>
  <row row="0">
   <cell col-end="0" col-start="0" row-end="0" row-start="0" text="Advance of knowledge regarding LC-NE system">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="0" row-start="0" text="Relation to schizophrenia">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
  </row>
  <row row="1">
   <cell col-end="0" col-start="0" row-end="1" row-start="1" text="Specificity in LC projections to frontal regions, neuronal constitution and physiology (Section
           
            2.1.1
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="1" row-start="1" text="A disruption of the specific action that NE exerts on PFC circuits may underlie cognitive abnormalities observed in SCZ (Section
           
            3.2
           
           ).">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
  </row>
  <row row="2">
   <cell col-end="0" col-start="0" row-end="2" row-start="2" text="LC activity coupled to brain oscillatory activity (Section
           
            2.1.1
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="2" row-start="2" text="Signatures of abnormal brain oscillatory activity are related to neurotransmitters and neuromodulators (Section
           
            3.3
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
  </row>
  <row row="3">
   <cell col-end="0" col-start="0" row-end="3" row-start="3" text="NE and DA co-release from LC terminals (Section
           
            2.1.4
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="3" row-start="3" text="NE/DA co-release may mediate the action of atypical pharmacological agents (Section
           
            3.5.2
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
  </row>
  <row row="4">
   <cell col-end="0" col-start="0" row-end="4" row-start="4" text="Signatures of LC activity during cognition in humans (Section
           
            2.2.3
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="4" row-start="4" text="Reduction of pupillometry and P3 signatures in SCZ during attention (Section
           
            3.3
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
  </row>
  <row row="5">
   <cell col-end="0" col-start="0" row-end="5" row-start="5" text="Role of LC in motivation to engage effort (Section
           
            2.2.3
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="5" row-start="5" text="Reduction of pupillometry signatures with increased effort (Section
           
            3.3
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
  </row>
  <row row="6">
   <cell col-end="0" col-start="0" row-end="6" row-start="6" text="GANE model of NE-glutamate interplay explains arousal-mediated effect of salient events (Section
           
            2.1.3
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="6" row-start="6" text="Altered function of molecules related to synaptic plasticity abnormally interact with neuromodulation in SCZ (Section
           
            3.2
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
  </row>
  <row row="7">
   <cell col-end="0" col-start="0" row-end="7" row-start="7" text="Network-reset and gain models of the effects of LC-NE system on switching and enhancement of brain networks’ activity (Section
           
            2.2.2
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="7" row-start="7" text="Lower signal-to-noise ratio of cortical circuits in SCZ (Section
           
            3.2
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
  </row>
  <row row="8">
   <cell col-end="0" col-start="0" row-end="8" row-start="8" text="Models of variability in LC recruitment and regulation of networks interaction explains traits such as working memory capacity (Section
           
            2.2.3
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="8" row-start="8" text="Triple-network model and reduced working memory capacity in SCZ (Section
           
            3.3
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
  </row>
  <row row="9">
   <cell col-end="0" col-start="0" row-end="9" row-start="9" text="Models of how LC-NE system controls the expression of brain states, i.e. stress (Section
           
            2.3.2
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
   <cell col-end="1" col-start="1" row-end="9" row-start="9" text="Susceptibility to stress is related to the symptomatology of SCZ (Sections
           
            3.3
           
           and
           
            3.4
           
           )">
    <evidence statement_id="0" type="" version="">
    </evidence>
    <evidence statement_id="1" type="" version="">
    </evidence>
    <evidence statement_id="2" type="" version="">
    </evidence>
    <evidence statement_id="3" type="" version="">
    </evidence>
    <evidence statement_id="4" type="" version="">
    </evidence>
    <evidence statement_id="5" type="" version="">
    </evidence>
    <evidence statement_id="6" type="" version="">
    </evidence>
    <evidence statement_id="7" type="" version="">
    </evidence>
    <evidence statement_id="8" type="" version="">
    </evidence>
    <evidence statement_id="9" type="" version="">
    </evidence>
   </cell>
  </row>
  <statements>
   <statement id="0" text="Triple-network model and reduced working memory capacity in SCZ (Section ) is in relation to schizophrenia in a disruption of the specific action that ne exerts on pfc circuits may underlie cognitive abnormalities observed in scz (section )." type="">
   </statement>
   <statement id="1" text="Reduction of pupillometry signatures with increased effort (Section ) is in relation to schizophrenia in a disruption of the specific action that ne exerts on pfc circuits may underlie cognitive abnormalities observed in scz (section )." type="">
   </statement>
   <statement id="2" text="The value Reduction of pupillometry and P3 signatures in SCZ during attention (Section ) belongs to relation to schizophrenia in a disruption of the specific action that ne exerts on pfc circuits may underlie cognitive abnormalities observed in scz (section )." type="">
   </statement>
   <statement id="3" text="NE/DA co-release may mediate the action of atypical pharmacological agents (Section ) is in relation to schizophrenia in a disruption of the specific action that ne exerts on pfc circuits may underlie cognitive abnormalities observed in scz (section )." type="">
   </statement>
   <statement id="4" text="The value Signatures of abnormal brain oscillatory activity are related to neurotransmitters and neuromodulators (Section ) belongs to relation to schizophrenia in a disruption of the specific action that ne exerts on pfc circuits may underlie cognitive abnormalities observed in scz (section )." type="">
   </statement>
   <statement id="5" text="Susceptibility to stress is related to the symptomatology of SCZ (Sections and ) is in relation to schizophrenia in a disruption of the specific action that ne exerts on pfc circuits may underlie cognitive abnormalities observed in scz (section )." type="">
   </statement>
   <statement id="6" text="Lower signal-to-noise ratio of cortical circuits in SCZ (Section ) is in relation to schizophrenia in a disruption of the specific action that ne exerts on pfc circuits may underlie cognitive abnormalities observed in scz (section )." type="">
   </statement>
   <statement id="7" text="Altered function of molecules related to synaptic plasticity abnormally interact with neuromodulation in SCZ (Section ) is in relation to schizophrenia in a disruption of the specific action that ne exerts on pfc circuits may underlie cognitive abnormalities observed in scz (section )." type="">
   </statement>
   <statement id="8" text="Relation to schizophrenia in a disruption of the specific action that ne exerts on pfc circuits may underlie cognitive abnormalities observed in scz (section ). has all unique values." type="">
   </statement>
   <statement id="9" text="Relation to schizophrenia in a disruption of the specific action that ne exerts on pfc circuits may underlie cognitive abnormalities observed in scz (section ). always has the same value." type="">
   </statement>
  </statements>
 </table>
</document>
